These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3353441)

  • 1. Protection by opioids against gastric lesions caused by necrotizing agents.
    Ferri S; Speroni E; Candeletti S; Cavicchini E; Romualdi P; Govoni P; Marchini M
    Pharmacology; 1988; 36(2):140-4. PubMed ID: 3353441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indomethacin on opioid-induced gastric protection in cold-restrained stress.
    Scoto GM; Parenti C; Scoto E; Spadaro C; Arrigo-Reina R
    Life Sci; 1991; 48(9):867-71. PubMed ID: 1997788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of morphine and met-enkephalin analogue on gastric lesions induced by indomethacin.
    Spadaro C; Arrigo-Reina R; Scoto GM
    Pharmacol Res Commun; 1987 Mar; 19(3):223-30. PubMed ID: 3602043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral sites of action for the protective effect of opioids of the rat stomach.
    Ferri S; Arrigo-Reina R; Candeletti S; Costa G; Murari G; Speroni E; Scoto G
    Pharmacol Res Commun; 1983 Apr; 15(4):409-18. PubMed ID: 6306698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opioid peptide DAMME modulates histamine's content in gastric mucosa of the rat.
    Speroni E; Govoni P; Guizzardi S; Ferri S
    Peptides; 1996; 17(6):957-64. PubMed ID: 8899814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against necrotizing agents-induced gastric lesions in rats. Unrelated to inhibition of gastric motility.
    Gutiérrez-Cabano CA
    Dig Dis Sci; 1994 Sep; 39(9):1864-71. PubMed ID: 8082492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man.
    Lightman SL; Langdon N; Forsling ML
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1447-9. PubMed ID: 7440706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the actions of naloxone and morphine on gastric acid secretion and gastric mucosal damage in the rat.
    Debreceni A; Debreceni B; Mózsik G
    J Physiol Paris; 1997; 91(3-5):189-97. PubMed ID: 9403793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by mild irritants against indomethacin-induced gastric mucosal damage in the rat: role of prostaglandin synthesis.
    Ligumsky M; Sestieri M; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1986 Nov; 22(11):807-11. PubMed ID: 3098701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H; Hamada K; Taga F; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH1-24 counteracts the prolactin-releasing effect of an opioid.
    Ferri S; Cocchi D; Locatelli V; Spampinato S; Muller E
    Eur J Pharmacol; 1982 Jan; 77(2-3):143-5. PubMed ID: 6277660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof for histaminergic but not for adrenergic involvement in the growth hormone-releasing effect of an enkephalin analog in the dog.
    Casanueva F; Betti R; Cocchi D; Chieli T; Mantegazza P; Müller EE
    Endocrinology; 1981 Jan; 108(1):157-63. PubMed ID: 7460816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroprotective effect of malotilate in indomethacin- and ethanol-induced gastric mucosal damage.
    Mirossay L; Mojzis J; Sallingová Z; Bodnar J; Benický M; Böör A; Kohút A
    Physiol Res; 1996; 45(5):405-11. PubMed ID: 9085369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG evidence that morphine and an enkephalin analog cross the blood-brain barrier.
    Kastin AJ; Pearson MA; Banks WA
    Pharmacol Biochem Behav; 1991 Dec; 40(4):771-4. PubMed ID: 1687763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine inhibits the ethanol-induced gastric damage in rats.
    Gyires K
    Arch Int Pharmacodyn Ther; 1990; 306():170-81. PubMed ID: 2076046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interrelationships between the development of ethanol-, HCl, NaOH and NaCl-induced gastric mucosal damage and the gastric mucosal superoxide dismutase activity in the rats.
    Mózsik G; Jávor T; Zsoldos T; Tigyi A
    Acta Physiol Hung; 1984; 64(3-4):309-14. PubMed ID: 6532119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.